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ABSTRACT 
We developed a method for the analysis of the main metabolic products of utilization of glucose by isolated 
adipocytes. They were incubated 24 h with 14C-glucose. The final label distribution and cold levels of medium glucose, 
lactate and glycerol were estimated. Medium lactate was extracted using ion-exchange resin minicolumns prepared 
with centrifugation-filtering tubes in which the filter was substituted by the resin. This allowed complete washings using 
only 0.2 mL. Repeated washings allowed for complete recovery of fractions with low volumes passing through or 
retained (and eluted), which allowed precise counting and sufficient sample for further analyses. Lactate was separated 
from glucose and glycerol; glucose was then separated by oxidizing it to gluconate with glucose oxidase, and glycerol 
was separated in parallel by phosphorylation with ATP and glycerol kinase. Cells' lipid was extracted with ether and 
saponified. Glycerides-glycerol and fatty acids (from the soaps) were counted separately. The complete analysis of 
cells incubated with labelled glucose resulted in about half of the glucose metabolized in 24 h, 2/3rds of the incorporated 
glucose label was found as lactate, 14 % as free glycerol. Their specific activities per carbon were the same as that of 
glucose. Production of fatty acids took about 5 % of the label incorporated, a similar amount to that of glycerides-
glycerol and estimated carbon dioxide. The procedure described is versatile enough to be used under experimental 
conditions, with a high degree or repeatability and with only about 3 % of the label not accounted for. 
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INTRODUCTION 
The application of quantitative factors in the 
analysis of metabolic pathways allows a better 
understanding of main substrate partition, energy 
handling and inter-organ cooperation, both under 
physiological and pathological conditions 1, 2. Most of 
these studies imply the tracing of 14C and 3H-labelled 
substrates 3, 4, more recently substituted (in part) by 
stable isotopes 5. The concurring availability of new 
powerful analytical techniques, largely based on mass 
spectrometry 6, and the extended, albeit unjustified, 
assumption to consider that our knowledge of the main 
metabolic pathways and their bulk regulation and 
operation are already well known, has certainly 
decreased the use of tracer techniques using 
radioactive labelled compounds. In any case, 14C-
labelled substrates remain the best option for studies of 
metabolic interconversion in which small amounts of 
material, and the absence of environmental control or 
major ethical constraints, allow their specific utilization. 
White adipose tissue (WAT) is a disperse organ 7, 
distributed in a number of locations in which its basic 
energy storage activity 8 is complemented by many other 
physiological functions 9-11. In any case, its main role is 
to contribute to the defense of energy homoeostasis, 
helping to control glucose 12, lipid 13, and amino acid 14 
metabolism overall, sharing a large part of the control of 
whole body energy availability 15, but acting also as a 
platform for immune system protection and regeneration 
16, 17. The complex (and varying) mixture of cell types in 
WAT sites largely determines and modulates these 
functions as part of its protean adaptability 16, 18.  
Most of WAT volume corresponds to a relatively 
small number of adipocytes. The rest of cells (stromal) 
is made up of immune system, stem, blood, endothelial, 
and other types of cells 19, 20, which often play critical 
functions under conditions of inflammation and 
maintenance of energy homoeostasis 21, 22. Adipocytes, 
despite their small numbers but large volumes most of 
which is fat, have been intensely studied as the most 
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"representative" cells of WAT 23. To clarify their 
metabolic abilities, they are often isolated from WAT 
masses and studied in primary 24 or immortalized 25 cell 
cultures. The information obtained is often taken as 
directly representative of WAT in vivo, in spite of the 
large number of factors that are known to counter this 
simplistic approach 26, 27.  
Many studies on adipocytes have been done using 
standard murine cell lines, as we recently did, finding 
that, under normoxic conditions, 3T3L1 cells converted 
to lactate enormous amounts of the medium glucose 28 
covering most of their energy needs through anaerobic 
glycolysis. We postulated that this "wasting" of glucose 
might actually help to diminish hyperglycemia because 
of the large combined mass of WAT; in ex vivo studies; 
we also observed the accumulation of lactate in WAT 
masses 29, in line with the results previously observed in 
cultured cells. These results agreed with the low in vivo 
WAT oxygen consumption observed in humans and rats 
30, 31 parallel to its high production of lactate 32, 33. 
However, the origin of the circulating lactate could not 
be fully discerned (other than by bulk mass), leaving 
open its possible relationship with the utilization of 
glucose for other purposes, such as lipogenesis 34. Fatty 
acid synthesis is a main metabolic pathway in the WAT 
of rodents fed standard (largely carbohydrate-based) 
diets 35. In order to help clarify the purpose of the 
massive production of lactate, we decided to analyze 
quantitatively the fate of glucose using primary cultures 
of rat adipocytes, but first we had to develop the 
necessary methodology to carry out the study applied to 
the small volumes used in standard cell culture.  
Separation of glucose (uncharged molecules) from 
(ionized) lactate has been done for a long time using 
ionic-interchange columns 36, 37. However, the problems 
posed by this approach limit the quantitative analyses, 
since high specific activity substrates are needed, and 
the large volumes required for effective ion-exchange 
column separation, washings and the inevitable dilution 
of label limit the possibility of using a multifaceted 
quantitative approach. In the present study, we adjusted 
this concept to the use of small volumes, thus limiting 
most of the unwanted effects of dilution by using a 
column centrifugation-based approach. These 
procedures allowed us to analyze, in the same culture 
well, both the fate of glucose to form lactate and its 
incorporation to lipids
 
EXPERIMENTAL 
Rats and housing conditions 
All animal handling procedures and the 
experimental setup were in accordance with the animal 
handling guidelines of the corresponding European and 
Catalan Authorities. The Committee on Animal 
Experimentation of the University of Barcelona 
specifically authorized the procedures used in the 
present study. 
Male Wistar rats (Harlan Laboratory Models, Sant 
Feliu de Codines, Spain) were used after a 2-week 
acclimation period in a controlled environment. When 
used, the rats were 17-weeks old, and weighed 412±35 
g). The animals were kept in two-rat cages with wood 
shards as bedding material, at 21.5-22.5ºC, and 50-60% 
relative humidity; lights were on from 08:00 to 20:00. 
They had unrestricted access to water and standard rat 
chow (Harlan-Teklad  #2014).  
Isolation and measurement of the number of 
adipocytes 
The rats were killed under isoflurane anesthesia, 
at the beginning of a light cycle, by exsanguination, from 
the exposed aorta, using dry-heparinized syringes. The 
rats were rapidly dissected, taking samples of 
epididymal WAT. Tissue pieces were used immediately 
for adipocyte isolation. This procedure followed, 
essentially that described by Rodbell 38. In short, tissue 
samples were weighed when already immersed in the 
digestion medium described below, and cut in small 
pieces with scissors. Samples were incubated, at 37 ºC 
in a shaking bath for 60 min, with 2.5 volumes of Krebs-
Henseleit medium pH 7.4, containing 5 mM glucose, 0.1 
µM adenosine (Sigma-Aldrich, St Louis, MO USA) 39, 
and 10 g/L delipidated bovine serum albumin (Merck-
Millipore, Billerica, MA USA). The medium was 
complemented with 3.5 µkat/mL collagenase 
(LS004196, type I, from Worthington Biomedical, 
Lakewood, NJ USA). At the end of the digestion 
process, the suspensions were gently "filtered" through 
a double layer of nylon mesh hose, which retained small 
vessels and undigested pieces (if any). The smooth 
crude suspension of isolated cells was left standing for 
5 minutes in capped syringes held vertically. The 
adipocytes floated to form a defined upper layer; then, 
the lower aqueous fraction was slowly drained off, 
capping again the syringe. The cells were washed three 
times with 2.5 volumes of the digestion buffer minus 
collagenase. The final supernatant layer contained 
intact adipocytes and a small amount of free fat from 
broken cells. In all cases, before re-suspending the 
cells, the buffer alone was subjected to 30 s of strong 
vortexing, to allow for equilibration with air oxygen. After 
the final washing, only the cells' fraction remained, from 
which aliquots were taken for incubation. The samples 
were extracted from the central part of this layer, trying 
not to disturb the thin floating fat layer. The whole 
procedure was carried out at room temperature; the 
cells were used immediately after the final washing.  
A known volume of the adipocyte suspension was 
introduced in a Neubauer chamber (#717810 Neubauer 
improved bright line, Brand Gmbh, Wertheim Germany). 
Using an inverted microscope, four fields (following a 
pre-established selection pattern) were photographed at 
low power. Each adipocyte suspension sample was 
measured four times, obtaining about 16 photographs 
from each. The numbers and diameters of cells were 
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counted (under the conditions used, all cells adopted a 
spheroid form) using the ImagingJ software 
(http://imagej.nih.gov/ij/) 40 for image analyses. 
Conditions for the incubation of adipocytes 
Incubations were carried out using 12-well plates 
(#CLS3513 Costar, Sigma-Aldrich) filled with 1.7 ml of 
DMEM (#11966-DMEM-no glucose; Gibco, Thermo-
Fisher Scientific, Waltham MA USA), supplemented with 
30 mL/L fetal bovine serum (FBS, Gibco). The medium 
also contained 25 mM hepes (Sigma-Aldrich), 2 mM 
glutamine (Lonza Biowhittaker, Radnor, PA USA), 1 mM 
pyruvate (Gibco), 30 g/L delipidated bovine serum 
albumin (Millipore Calbiochem, MA USA), 100 U/mL 
penicillin and 100 mg/L streptomycin (Gibco, Thermo-
Fisher Scientific). Adenosine (Sigma-Aldrich) 100 nM 
was also added to help maintain the integrity of the cells 
39. D-glucose was added as substrate, supplemented 
with 14C-(U)-D glucose, (#ARC0122B, American 
Radiolabeled Chemicals, St Louis MO USA, specific 
activity 11 GBq/mmol, i.e 1.83 GBq/mmol-C). Final 
glucose concentration in the wells was, nominally, 7 
mM. In all cases, the amount of label added per well was 
the same: 4.7 kBq (i.e. 430 pmol 14C-glucose) resulting 
in specific activities in the range of 385 Bq/µmol. 
Labelled glucose was purified through a single pass of 
the product through an ion-exchange column as 
described below under Estimation of medium label 
present in the "glucose" fraction. The removal of ionic 
contaminants contributed to diminish the overlapping of 
label between the different fractions. 
Each well received 400  µL of the adipocyte 
suspension, thus completing a final volume of 2.1 mL. A 
number of random counts of cells pipetted in wells gave 
a variation of about 2 % in initial cell numbers, the 
standard amount of cells used (702±46 x 103 cells per 
well) depended on the donor rat. Since the combined 
volume of the added cells was known, the net volume of 
incubation medium (i.e. excluding cell volume) was 
calculated for each single well from the initial volume 
and that of buffer added with the cells. This was 
estimated from the total volume of cell suspension 
added minus the volume of cells, obtained from the 
mean cell volume and the number of cells counted. 
Under these conditions, the cells floated freely and 
tended to accumulate on or near the surface 
The cells were incubated at 37°C in an incubation 
chamber ventilated with air supplemented with 5% CO2, 
which gave a theoretical pO2 of 20 kPa (i.e. 0.2 mM of 
dissolved O2). These values were in the range of those 
measured under the same conditions 28. The calculated 
pCO2 was in the range of 5 kPa, corresponding to 1.7 
mM of dissolved CO2 41. The cells were incubated for 24 
h without any further intervention. 
The rate of evaporation of water from the medium 
was estimated, under the conditions of incubation, using 
medium-filled wells (i.e. no cells), and measuring the 
loss of weight with time of incubation in the chamber. 
Daily evaporation was in the range of 2.5 % of the well 
water (i.e. about 48 µL/day). This value was included in 
the estimation of the volume of medium, used for all 
calculations of substrate utilization. 
Cell harvesting and sample handling 
The medium (carefully excluding the floating 
adipocytes) of the wells was transferred to 2 mL 
Eppendorf tubes. The cells (and the remaining medium 
bathing them) were transferred to another tube and left 
standing. All media extractions were combined in a 
single tube and its weight was estimated by differential 
weighing;after thorough mixing, it was kept at -20 ºC 
until processed. The cells were weighed likewise and re-
suspended in 2 volumes of digestion buffer (without 
collagenase), pH 7.4, and containing 5 mM glucose; 
then, they were allowed to float again, removing the 
infranatant washing medium. The cells were then frozen 
in the same tube with liquid nitrogen and kept at -80 ºC 
until processed. 
The incubation medium was used for the 
estimation of glucose, using a glucose oxidase-
peroxidase kit (#11504, Biosystems, Barcelona Spain) 
to which we added 740 nkat/mL mutarrotase (porcine 
kidney, 136A5000, Calzyme, St Louis, MO USA) 42. 
Lactate was measured with kit 1001330 (Spinreact, Sant 
Esteve d'en Bas, Spain), pyruvate was measured with 
NADH (Calbiochem EMD Millipore Merck, Darmstadt, 
Germany), and lactate dehydrogenase (rabbit muscle, 
427217, Calbiochem EMD-MiIllipore Merck) 43; glycerol 
was estimated with kit #F6428 (Sigma-Aldrich). We 
decided to analyze the chemical concentrations of 
substrates in samples despite being tainted by 
radioactive tracers in order to be able to exactly match 
concentrations and label counts. We used that approach 
because of the small amounts of radioactivity involved, 
and the lower ionizing power of 14C. β radiation These 
analyses were done under conditions of high 
radioprotection safety. Debris and contaminated 
materials was safely disposed of as radioactive waste.  
Estimation of label content 
Counting of 14C label in the samples was done 
using typical 5 mL polyethylene vials. Samples of up to 
400 µL were mixed with at least 10 volumes (minimum 
3.5 mL) of water-miscible liquid scintillation cocktail 
(Ecoscint H; #LS-275, National Diagnostics, Atlanta, GA 
USA). Then, the tubes were shaken to obtain a single 
clear phase. They were left in the dark (at room 
temperature) for at least 12 h before being introduced in 
a scintillation counter (TriCarb 2100-TR, Perkin-Elmer 
Packard, Boston, MA USA). Automatic correction for 
counting efficiency was applied, and a number of blanks 
was introduced in each series to estimate the 
background, which was routinely discounted. When 
sufficient sample was available, counting was done in 
duplicate. Specific radioactivity of the different fractions 
was expressed (and compared) on a molar (per carbon) 
basis. Thus total label (i.e. x Bq) in 1 µmol glucose was 
expressed in (x/6) Bq/µmol-C, because the glucose 
used was uniformly labelled in its 6 carbon atoms. In the 
case of lactate and glycerol, the factor used was 3, and 
for fatty acids, we used oleic acid (C18:1;9) as standard 
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for comparisons because it is the most abundant fatty 
acid in the rat 44; thus the molar specific activity of fatty 
acids was divided by 18 to obtain the molar-C (i.e. per 
carbon) value. 
Preparation of micro ion-exchange columns 
The basis for discrimination of the main substrates 
analyzed was the use of ion-exchange resins in 
microcolumns. The prepared columns were able to 
retain quantitatively ionized molecules, such as lactate 
at a pH in which its ionization will be sufficiently high, but 
non-ionic (acidic in the present setting) compounds such 
as glucose and glycerol would pass unaffected through 
the column. The acid retained in the column was later 
displaced with a low pH solution, releasing the lactate 
(and pyruvate) label.  
Sieve-filter type centrifugation inserts (Ultrafree-
MC, Millipore, Bedford, MA USA) were used as columns. 
The sieve filter was removed, leaving bare the insert 
plastic tube (Figure 1). A small amount of analytical 
quality glass-fiber wool (Panreac, Castellar del Vallès, 
Spain) was used to cover the bottom of the insert tube, 
pressed with the help of a glass rod. The bottom of the 
insert was then filled with 250 mg of 24 h-hydrated and 
centrifuge spin-dried ion-exchange resin in cationic form 
(Dowex 1x2 [200-400 mesh], Serva Electrophoresis 
GmbH, Heidelberg, Germany). The insert was 
introduced in the holder tube and then 200 µL of pure 
water (18 MΩ resistivity) was added to the column. The 
tubes were centrifuged for 2 min at 200xg. The 
recovered washing fluid was discarded. The column was 
already prepared for immediate use. 
Overview of label distribution analysis after 
incubation 
We used a sequential process for the separation 
and counting of fractions corresponding, essentially, to 
the main metabolites expected to be formed from 
glucose. The procedure used is presented in Figure 2. 
At the end of the incubation of adipocytes in media 
containing labeled glucose, the cells were separated 
from the medium and processed as described below. 
The medium was passed though ion-exchange 
minicolumns (procedure M1) to retain all ionizable 
compounds (i.e. lactate), which were later recovered 
and counted (procedure M2). This process depleted the 
medium of ionizable (labelled) compounds; but 
containing all non-ionizable (i.e. glucose, glycerol) ones. 
These were separated through derivatization to a 
specific acidic compound (gluconate in the case of 
glucose, procedure M3; glycerol-3P in the case of 
glycerol, procedure M4) by means of parallel 
incubations of the depleted medium. The recovered 
fractions allowed a fair discrimination of the label 
present in the medium remaining glucose and that in 
lactate and glycerol. 
Estimation of medium label present in the "lactate" 
fraction 
The basic protocol for column retention of acidic 
compounds (procedure M1) consisted of the application 
of 300 µL of the incubation medium (its pH was already 
in the range 6.8-7.2) on top of the column. The tubes 
were capped and left standing for 4 min to allow an even 
distribution of the liquid wetting the resin. No fluid left the 
column, since the mobile phase was retained by 
capillarity. The tubes were then centrifuged 2 min at 
200xg (i.e. 20 MPa). The fluid recovered (about 300 µL) 
was reserved (washout 1, or W1). In order to remove 
any non-ionic labeled remnants, the column was 
washed with 200 µL of pure water, quantitatively 
recovering the washout (W2). The column was then 
eluted (procedure M2) with the addition (and separation 
by centrifugation) of four successive 200 µL aliquots of 
250 mM HCl, recovering the combined acidic eluates 
(W3). Finally, the column was washed again with 200 µL 
of pure water (W4). This procedure extracted all ionic 
labelled compounds of the medium previously retained 
by the column; the combined volume of W3+W4 was 
about 1 mL. Depending on the volume to process and 
sample dilution, higher volumes of medium were used, 
or pairs of columns could be used in tandem. The 
radioactivity of the samples was estimated after 
neutralization with solid sodium bicarbonate, in order to 
limit the acid-generated quenching. 
In order to check the effectiveness of the columns, 
an analysis of lactate label distribution was carried out 
under otherwise standard conditions (but no cells). We 
used cold (5 mM) and labeled L-lactate [317 Bq/well] 
(14C-(U)-L-lactate; #NEC-599, Perkin-Elmer, Boston, 
MA USA; specific activity 4.80 MBq/µmol, i.e. 1.60 
MBq/µmol-C). Table 1 shows the distribution of total 
label between the different fractions recovered. 
The column completely retained the lactate label; 
its elution was practically complete with the first 400-600 
µL of HCl; the successive washings did not provide 
further recoveries of lactate label. The final process was 
established leaving only one additional water washing, 
which was used, in all the cases, to check for the 
completeness of column elution. When label was 
detected in the second washout (it was always less than 
5% of that in the first washing), the net Bq were simply 
added to the corresponding column washout for final 
calculations. 
Estimation of medium label present in the "glucose" 
fraction 
After retention of lactate in the ion-exchange 
column, the medium (plus the water washing) passing 
through (W1 + W2) contained the entire non-retained 
glucose label. We modified enzymatically the glucose to 
gluconic acid by means of the same glucose-oxidase 
method used to measure its levels (procedure M3). 
Aspergillum glucose oxidase (EC 1.1.3.4) 
specifically oxidizes C1 of glucose with oxygen to yield 
gluconic acid and hydrogen peroxide 45: 
β-D-glucose+ O2  →  D-glucono-β-lactone + H2O2 
D-glucono-β-lactone + H2O → D-gluconic acid 
 (Spontaneous, non-enzymatic hydrolysis) 
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This same reaction has been used previously to 
discriminate the presence of radioactive label in glucose 
46 using classical minicolumns filled with an ion-
exchange resin (cationic form) adapted to the retention 
of acidic compounds (as in the case described above for 
lactate) 37. In order to diminish possible sources of 
interference, we used purified enzymes, glucose 
oxidase (type VII from Aspergillus niger, Sigma-Aldrich); 
as well as catalase (from bovine liver, Sigma-Aldrich). 
Catalase (EC 1.11.1.6) was added in excess to drive the 
reaction to the right, to limit unwanted oxidative damage 
and to recycle part of the medium oxygen to sustain the 
glucose oxidase activity, since oxygen availability may 
be the limiting step of the reaction under the conditions 
tested. 
2H2O2 → 2H2O + O2 
The addition of mutarotase (EC 5.1.3.3) to favor 
the conversion of α to β glucose 47 was considered 
unnecessary because of the length of the incubation 
period (allowing for a complete drainage of α-glucose to 
the β form, substrate of glucose oxidase). A test 
including mutarotase showed no effects in glucose 
oxidation under the experimental conditions described 
below. The test results, obtained using labelled glucose 
(initially most of it as the α-isomer), which resulted in its 
complete oxidation, was a definitive argument for 
omitting mutarotase in all the ensuing experiments. 
An aliquot –100 µL– of combined fractions W1 and 
W2 (eluted after lactate retention) was used for the 
measurement of total label. Another 100-µL aliquot was 
mixed with 1 mL of 50 mM acetate buffer pH 5.2, 
containing 1 g/L dithiothreitol, 1 g/L defatted bovine 
serum albumin (all from Sigma-Aldrich), about 400 nkat 
of glucose oxidase and an excess (350 µkat) of catalase 
in open Eppendorf tubes. They were incubated 
overnight at room temperature. The long incubation was 
not justified by the high enzyme load added, but by the 
need to maintain an adequate interchange with 
atmospheric oxygen to allow a prompt oxidation of 
glucose by glucose-oxidase. The periodic ventilation of 
samples with small volumes (10 mL) of air using 
syringes and a capillary tube showed no significant 
effect on the effectiveness of the reaction, and was 
cumbersome. Thus additional ventilation was not 
considered further, using time and passive gas diffusion 
instead. The incubation was stopped by the addition of 
1 mL of 20 mM glycine buffer pH 9.8 containing 0.5 mM 
MgCl2, changing the medium pH to 8.5. Then, the 
sample was divided in two aliquots of the same volume, 
which were passed through two parallel Dowex 1x2 
columns as described previously for the M1 procedure. 
The washouts W5+W6 from both columns were 
combined, and were used to determine the label content 
of the fraction. The label in W5 and W6 did not 
correspond to glucose but to glycerol, and (possibly) 
other unknown nonionic compounds, which were not 
substrates for glucose oxidase.  
The label retained in the column was eluted 
following the same procedure described above for 
lactate, which yielded washouts W7 and W8 (total 
volume of 1 mL), which were counted using several 
scintillation vials. They contained the eluted gluconic 
acid which label was that of the original glucose present 
in the medium. 
In order to check the effectiveness of the 
derivatization procedure, an analysis of glucose label 
distribution was carried out under otherwise standard 
conditions. As shown in Table 1, the conversion of 
glucose to acidic-labeled compounds (essentially 
gluconate) was quantitative, being retained in the 
minicolumn. Elution with HCl released, again, 
quantitatively the glucose label. 
Estimation of medium label present in the "glycerol" 
fraction 
As outlined above, after retention of lactate in the 
ion-exchange column, washouts W1 + W2 contained the 
entire non-retained nonionic label (i.e. glucose and 
glycerol, essentially). However, to find out whether the 
label corresponded to glycerol, we used a specific 
enzymatic reaction to convert all free (nonionic) glycerol 
to an ionic form retaining the label (procedure M4). 
Glycerol kinase (EC 2.7.1.30) specifically esterifies 
glycerol with ATP to yield glycerol-3P and ADP 48: 
glycerol + ATP → glycerol-3P+ ADP 
This same reaction has been used previously to 
discriminate the presence of radioactive label in glycerol 
49, using an ion-exchange resin to retain all acidic 
compounds (i.e. remaining ATP, ADP and glycerol-3P). 
In order to diminish possible sources of interference, we 
used a purified enzyme, glycerol kinase from 
Escherichia coli (#G6278, Sigma-Aldrich). 
A 100 µL aliquot of combined fractions W1 and W2 
had been already used for the measurement of total 
label. Another 100-µL aliquot was mixed in an 
Eppendorf tube with 0.3 mL of 50 mM tris-HCl buffer pH 
9.8. The buffer also contained about 100 pkat of the 
enzyme, as well as disodium-ATP, streptomycin+ 
penicillin, magnesium acetate, lipid-free bovine serum 
albumin and dithiothreitol (all from Sigma-Aldrich) at 
final concentrations, respectively, of 8 mM, 10 mg/L + 10 
U/mL, 8 mM, 1 g/L and 1 g/L. The tubes were closed and 
incubated at room temperature. The incubation was 
stopped by adding 18 µL of 50 mM HCl to each sample; 
their pH decreased to about 7. Aliquots of the sample 
were passed through Dowex 1x2 columns as described 
previously for the M1 procedure. The washouts 
W9+W10 were combined, and used to determine their 
label content, that belonged essentially to glucose and 
other remaining compounds not susceptible of 
phosphorylation by glycerol kinase. 
The label retained in the column was eluted 
following the same procedure described above for 
lactate, which yielded washouts W11 and W12 (total 
volume of 800 µL), which were counted. They contained 
the eluted glycerol-P, which label was that of the original 
glycerol present in the medium. 
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This procedure showed a number of additional 
problems, not encountered in the case of glucose 
oxidation to gluconate. The amount of enzyme added 
was sufficient to convert the substrate in a few minutes, 
but initially we left the tubes under incubation overnight 
to make sure that all glycerol was phosphorylayted. 
However, we observed that the long incubation resulted 
in yields of label higher than expected in the W9+W10 
effluxes. In fact, the label obtained after retention of 
glycerol-3P in the column was higher than that found in 
the W5+W6 obtained as washouts of glucose retention. 
We traced the discordance to the presence of glucose 
in the glycerol incubation with glycerol-kinase, and to the 
fact that the M1 procedure removed the antibiotics 
present in the medium, which prevented the growth of 
microorganisms. The differences between the fractions 
indicated above were due to such growths yielding 
lactate or other acids. The problem was solved 
reintroducing the antibiotics in the glycerol-kinase 
incubation medium, as indicated above in the general 
procedure. The results of this test can be seen in Table 
2. This was only part of the problem, since using labelled 
glucose and no glycerol standards, part of the glucose 
was retained in the columns. The long incubation, thus, 
resulted, in a partial ionization (phosphorylation?) of 
glucose, yielding erroneous label values for glycerol. 
The problem was finally solved cutting down the 
incubation time to only 2 hours and increasing the 
amount of glycerol kinase to the 100 pkat indicated 
above. 
In order to check the effectiveness of the specific 
derivatization procedure used for glycerol, an analysis of 
its label distribution was carried out under otherwise 
standard conditions. We used cold (1.3 mM) and 
labelled glycerol [242 Bq/well] (14C-(U)-glycerol, 
#CFB174 Amersham Pharmacia Biotech, Amersham 
UK; specific activity 5.25 MBq/µmol, i.e. 1.75 MBq/µmol-
C). Table 1 shows the distribution of total label in each 
case between the different fractions recovered. This 
experiment was done using an overnight incubation 
time, which can explain the relative variability of the 
results obtained when compared with lactate and 
glucose. The retention of label in the column was not 
quantitative, but almost, and the eluted fractions of label 
obtained with HCl allowed us to recover the initial label. 
Cell fraction handling 
Frozen (i.e. assumedly broken) adipocytes were 
used for the extraction of lipids (procedure C1, Figure 2), 
using diethyl-ether (peroxide-free, containing 7 ppm 
BHT, Sigma-Aldrich), in the proportion of about 1.5 mL 
of chilled diethyl ether for each sample (i.e. 179±22 mg) 
of frozen cells. The tubes containing the already freeze-
fractured cells were mixed by vortex several times and 
cells thawed while subjected to extraction in the cold. 
Then 500 µL chilled pure water were added and the 
tubes were briefly centrifuged (5 min at 600xg) and two 
phases appeared. The lower (aqueous) phase was 
suctioned off, including the delicate inter-phase film of 
protein (and membrane fragment) debris. This fraction 
was used for counting; it contained cell protein, (mainly) 
glycogen, metabolites, membrane microsomes and non-
lipophilic debris. The (upper) organic phase was 
recovered, left to dry at room temperature and weighed. 
Then, the lipid residue was dissolved/ mixed with 2 mL 
of diethyl-ether and 1.5 mL of hydroalcoholic KOH. The 
latter was prepared immediately before use by mixing 1 
volume of 8.4 M potassium hydroxide (in water) with 3 
volumes of ethanol. The alkali broke down the 
acylglycerols through saponification, forming potassium 
soaps and freeing glycerol. The tubes were the reaction 
took place were vortexed and allowed to react at room 
temperature for 10 min (procedure C2). The tubes were 
then left to stand and two layers were separated, the 
bottom one contained the glycerides' glycerol. The 
upper phase promptly solidified and contained, 
essentially, the potassium soaps, not soluble in ether-
ethanol. The phases' weights were estimated, and the 
whole samples counted. 
The cells' fractioning was not checked using 
standards, as was the case of lactate and glucose, since 
its total retention of label was small, the procedure could 
not be repeated from scratch with known labelled 
compounds in the cells, and, especially, because all the 
manipulations described are common and have been 
previously used. Instead, the overall evaluation of the 
effectiveness of the whole process described was based 
on a precise accounting of the distribution of all label 
added to the incubation well. 
Additional methodologic considerations 
A critical factor in the development of this 
procedure was to keep track of volumes and incorporate 
into the calculations all aliquots used for testing (i.e. cold 
glucose or lactate levels, amount of label in a given 
fraction). Unless the whole fraction were used for 
counting, a sizeable part of it was used to determine its 
label content. All data were introduced in a spreadsheet 
in which the volumes were justified with a (pipetting) 
error of ± 3%. A similar error level was estimated for 
counts, which were routinely repeated and the mean 
value used. When possible, or when no other avenue 
was available, volumes were estimated from differential 
weights and the application of densities, estimated, as 
described, using the same samples. 
Statistical calculations and analyses were done 
using the Prism 5 package (Graph-Pad Software, La 
Jolla, CA USA).
 
RESULTS 
Experimental application of the method described. 
Analysis of label and substrates/ metabolites in fractions 
of incubated adipocytes  
 Cells from four different rats were used. The 
results obtained are presented in Tables 3-5. Table 3 
shows the composition of the media at the beginning of 
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the experiment and after 24 h of incubation. The data 
were given both in molar units and in well content of 
each metabolite analyzed.  
Table 4 presents the weights/volumes of samples, 
their label content and the extrapolation of the results to 
the whole incubation well, in spite of the size of the 
sample analyzed. The presence of label in the different 
fractions is presented as mean values of the four rats 
used.  
 Table 5 presents the specific radioactivity of the 
different fractions analyzed: both in the initial medium 
and after incubation and cell harvesting. We did not 
found sufficiently high levels of non-esterified fatty acids 
in the media to include them in the calculations. Lactate 
(plus pyruvate) and the remaining glucose showed 
values for specific radioactivity very close to those of the 
initial glucose used, which helps to support the 
adequacy of the methodology used. 
 As expected, we found much lower specific 
radioactivity, in lipids, with roughly half their label 
incorporated into fatty acids and the rest in the glycerol 
moiety of triacylglycerols. As expected, the specific 
radioactivity, expressed in Bq/µmol of C, of the 
remaining glucose, lactate (plus pyruvate), and medium 
free glycerol were the same as that of the glucose 
initially added to the cell cultures, which proved that the 
origin of the free 3C units was the glucose added to the 
medium. The specific activity of glycerides-glycerol was 
more than one order of magnitude higher than that of 
fatty acids, but much lower than that of the glycerol 
found in the medium. 
Final distribution of the glucose label 
 Figure 3 presents the results of the separation 
of medium and cell label in fractions. The data are a 
translation of the experimental figures shown in Table 4, 
and are expressed as percent values of the distribution 
of the label initially introduced in the incubation medium. 
Most of the label remained in the medium, about half as 
unused glucose. Thus, sufficient glucose remained after 
24 h to sustain the cells' metabolism. The other major 
label containing fractions in the medium were lactate (+ 
pyruvate) and glycerol. Cells incorporated only about 6 
% of the label, with a similar distribution of total label 
between glycerides-glycerol and fatty acids, but 
containing also a significant proportion of label in 
hydrophilic compounds (probably glycogen). In all, only 
c. 0.3 % of the cell label was not accounted for. This 
discrepancy was uncharacteristically small for this type 
of studies, and helps understand the limited number of 
molecule types that were marked from the glucose label 
in the relatively short time of incubation. The global loss 
of label was, similarly, low (in the range of 3 % overall) 
given the usual imprecision of separation of labelled 
compounds, probably because of reasons similar to 
those of the cells' label. 
 Figure 3 also shows the fate of label from the 
glucose actually metabolized. About two thirds 
corresponded to the lactate fraction, but the sum of free 
and triacylglycerol-incorporated glycerol accounted for 
1/5th of the total, which contrasts with the (low) 5 % of 
fatty acids. Since there was a definite, albeit small, net 
synthesis of fatty acids (they incorporated glucose 
label), we have necessarily to take into account the 
coexistence, in a mainly glycolytic environment, of 
oxidative processes (at least the pentose-phosphate 
pathway –or malic enzyme— and pyruvate 
dehydrogenase). The oxidative metabolism was 
necessary to provide NADPH and 2C units to build acyl-
CoA. The production of CO2 from glucose in the 
pentose-phosphate pathway yields 6 carbon-units as 
CO2 (i.e. equivalent to a whole glucose) for each 12 
NADPH produced; and pyruvate dehydrogenase 
produces another CO2 for each acetyl-CoA formed. To 
synthesize an 18C fatty acid we need 9 acetyl-CoA units 
and 2x8=16 NADPH; this results, necessarily, in the 
production of 9+8= 17 CO2, which is liberated for each 
fatty acid produced, i.e. roughly 1 CO2 per carbon in the 
fatty acid. The minimum oxidative needs for the 
metabolic picture depicted is the equivalent, in glucose 
units of the label in fatty acids of about 1/3rd of the label 
found in fatty acids. This is a minimum value, which does 
not preclude other oxidative pathways. It may be also 
lower than this figure depending on the activity of the 
malic enzyme as provider of cytoplasmic reducing 
power for lipogenesis. Thus, it is only an approximation 
to the actual oxidative capabilities of the adipocytes. In 
any case, the proportion of oxidative activities of 
adipocytes on the medium glucose could not go beyond 
a 4 % of metabolized glucose, which represents a 
maximum figure for measuring errors not corrected, 
including the variability of 14C counting, and the probable 
loss of cells and medium during the harvesting process. 
 
DISCUSSION 
We have developed a complex, but doable, 
procedure for analysis of the fate of a substrate, as is 
glucose, using a primary cell culture of adipocytes just 
extracted from WAT. There are a considerable number 
of procedures similar to this one, which have been used 
to follow up the uptake of labelled substrates 4, 50, or their 
(usually one-step) transformation, or oxidation 51. The 
problem, shared by all similar procedures, being largely 
the small volumes of media and cells used in cell culture, 
which strongly limits the actual amount of label that can 
be incorporated and, especially, the later analysis of the 
metabolites, intact substrate and distribution along 
different pathways. Studies using tissue pieces, sections 
or isolated cells have been used in the past for 
experiments such as those described here, but the 
critical step of quantitative separation of substrates 
requires a careful balance between the amount of 
tissue, medium (and labelled compounds) used, and the 
effects of dilution on label distribution. The 
measurement of labelled CO2 52, and up to a degree, its 
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incorporation in cells 53 or removal from the medium 54 
have been used often with success. However, the 
studies using perfused 55 or perifused 56 organs and 
incubations with pieces of tissue 57, now seldom used, 
have been the main methods available for analyses of 
the utilization of glucose and release of 3C units by live 
tissues. 
The objective of this study was to design a flexible 
system for the study of the metabolism of WAT cells (or 
tissue pieces) under well-controlled conditions, which 
can provide coherent results from a single incubation 
plate well. We have found, recently, that adipocytes 
glycolyze huge amounts of glucose to lactate and 
glycerol 28, acting, essentially, as an anaerobic tissue 
under normoxic conditions, such as those used in the 
present study, and this mechanism extends to the in vivo 
conditions 29. We have also found that WAT contains a 
full urea cycle 58 and a potentially active amino acid 
metabolism 14. The results obtained, and a growing list 
of unique capabilities of WAT 59-64 has decided us to 
focus on the quantitative analysis of WAT metabolism. 
Thus, we checked these parameters against the known 
functional and morphologic differences of WAT sites 65-
67, and their modulation by sex and diet 14, 68, as well as, 
especially, the effects of metabolic syndrome 69, 70. In our 
opinion, there is yet much to learn from WAT from the 
"basic" biochemical-metabolic point of view. We know 
much about its metabolic modulation by cytokines 71 and 
hormones 72-75, and even its responses to oxidative 
stress 76 and hypoxia 77, 78, however, we know very little 
on the quantitative importance of Randall's glucose-fatty 
acid cycle, the classical Cori cycle and the interchange 
of glutamine and ornithine-arginine with the splanchnic 
bed. Consequently, we developed a tool, which can be 
used for that purpose, adapted, modified, and, we hope, 
improved to fulfill its function. In the present study, we 
did a full experiment of label distribution on rat 
adipocytes, but our focus was not on the spectacular 
results (we plan to extend further these studies, in 
adequate depth), but on obtaining a proven tool to carry 
out these type of investigations. A test in toto seems the 
most adequate way to check the defects (and correct 
them) of such complex approach. The results may need 
further development for specific experiments, but the 
backbone of quantitative approaches and reduced 
column efflux may allow these developments further 
than presented here. 
The large volumes involved in the use of ion-
exchange columns, and the difficulties posed by the 
dilution of samples linked to their use makes difficult to 
discriminate a sufficient number of main metabolites 
from the same cell culture. This approach is of limited 
usefulness on modern cell culture (immortalized or 
primary); consequently, in the last decades, the use of 
these methods has been largely abandoned, in part 
because of the limited advantages of using radioactive 
tracers for the small volumes and live material mass 
involved in cell culture-based studies. The availability of 
other analytical tools and the focus set on regulation, 
assuming that the main metabolic pathways are already 
known have compounded the situation.  
In decreasing the handling of volumes needed for 
ion-exchange column separation, we developed a 
methodology that may be directly applicable to the 
analysis of metabolic flow of substrates in (at least 
primarily) adipose tissue cells. The critical points of the 
adaptation of existing methodology to the problem 
described have been:  
a) The use of micro-columns, which require 
microliter samples to process, by using centrifugation 
instead of simple gravity for eluent recovery, 
eliminating most of the contamination induced by 
capillary retention of effluents in the columns.  
b) The control of volumes and of presence of label 
in different fractions, including a critical analysis of 
losses (and possible sources of error) and 
incorporation of all data in the final computation of the 
results.  
c) To combine these label analyses with those of 
the main metabolites studied using standard micro-
analytical methods in the same well, and thus being 
able to compare the specific radioactivity of these 
fractions. This requires special training and care for 
non-label dependent analyses of labelled compounds, 
but the homology of the results achieved justifies the 
additional application of safety measures. 
The main problems posed by this type of 
methodology are already well-known: It is fairly difficult 
to match the "cold" measurements of concentrations 
and the analysis of the labelled fractions which, 
essentially, correspond to the same molecules. In the 
case of lactate, we were aware that this fraction 
contained a variable amount of pyruvate, in part 
because it is a standard component of the media for 
adipocytes (as is our case), but also for its known 
secretion by adipose tissue 33. Its formation is also a 
consequence of the production of glycerol; since the 
synthesis of glycerol-3P, redirects NADH from the 
glycolytic pathway (that generated by glycerol-3P 
dehydrogenase). This relative deficit of NADH in the 
main glycolytic pathway results in a relative excess of 
pyruvate (that cannot be reduced to lactate for lack of 
enough NADH to maintain the stoichiometry of the 
process). This "extra" pyruvate, however, was not fully 
directed to produce the acetyl-CoA later used to 
synthesize the fatty acids found in cells' triacylglycerols, 
Lipogenesis was limited, as observed in the difference 
between the label presence in the fatty acids and 
glycerol moieties of triacylglycerols, even not taking into 
account the free glycerol in the medium. However, the 
specific activity (per carbon unit) of lactate was in the 
same range than those of glucose and glycerol. The 
explanation is not simple, since pyruvate was retained, 
as was lactate in the columns in the first pass, but its 
"cold" levels were not measured as was the case with 
the major component, lactate. The specific activity of the 
"lactate+pyruvate" fraction should be, consequently, 
somewhat lower than that of glucose, unless we take 
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into account the preferential utilization of pyruvate for 
fatty acid synthesis. This possibility is supported by the 
specific activity of this fraction (per C) being similar to 
that of the other medium metabolites. 
It has been found that under hypoxic conditions WAT 
decreases the synthesis of acyl-CoA, storing less fat 77. 
WAT consumed very little oxygen in vivo 78, suggesting 
that its anaerobic glycolysis may sustain a sizeable 
amount of its needs 28 for an unexpectedly active 
metabolism 14. In fact, about 98.5 % of the adult large 
adipocytes such as those used here is made up of fat, 
the small active cytosol, however, has enzyme activities 
(i.e. lactate dehydrogenase, amino acid metabolism 
enzymes) in the range of most other tissues 14. 
The results obtained from the application of the 
combined study of label fate are in agreement with the 
known high production of lactate even under 
normoglycemic conditions. The specific activity of 
lactate is the same as that of the initial (and remaining) 
medium glucose. However, in spite of a largely glycolytic 
environment, there was a small but significant synthesis 
of fatty acids from glucose, stored in the enormous 
triacylglycerol stores. The animals used were normal 
adult males, thus, the glycolysis could not be attributed 
to hypoxia (the availability of oxygen was high), or 
metabolic stress/ inflammation.  
The data presented support the assumption that 
glucose is practically the only origin of the medium 
glycerol. The high specific activities found were much 
higher than what could be expected if the medium 
glycerol were produced via acyl-glycerol lipolysis, even 
if this were only a minor fraction of the total.  
In the adipocyte, the flow of label to glycerol (i.e. via 
glycerol-3P) was considerable, even when corrected by 
the number of carbons. We can only assume that a 
significant part of the glycerol-3P pathway resulted in the 
patent presence of high specific activity-glycerol in the 
medium 28. The results observed in the test of the 
method are, thus, coincident with those observed using 
other systems and conditions. The high label content 
and the absence of labelled fatty acids seems to confirm 
that glycerol, was not formed by lipolysis as previously 
postulated 79, 80, but if was formed directly from the direct 
conversion of glucose. 
In sum, the results we obtained in the samples of 
epididymal WAT analyzed agree with what we know of 
WAT, established using other means and techniques, 
but the results presented here contribute further to show 
the proportions of glucose carbon going through 
different pathways to form a combination of glycolytic 
and oxidative metabolism. The methodology we present 
may be especially useful to analyze the effects of 
substrate availability/ concentration, hypoxia, 
inflammation, regulatory factors on the modulation of 
these effects. 
 
CONCLUSIONS 
We have developed a systematic analysis of the 
fate of 14C-label from glucose in primary cultures of 
adipocytes. Its application to epididymal rat adipocytes, 
has allowed us to analyze in detail the proportion of label 
incorporated into medium lactate and glycerol. Cells 
glycerides' glycerol and fatty acids synthesis were also 
measured, thus setting the basis for a further 
confirmatory analysis of what we have found in this 
phase of methodological development. Specifically the 
full glucose (i.e. not lipolytic) origin of the glycerol 
secreted by adipocytes under conditions of abundant 
glucose in the medium, the predominance of an active 
glycolysis in adipocytes (i.e. high production of lactate) 
parallel to the (oxidative) synthesis of fatty acids, albeit 
the latter occurring in smaller proportions under the 
conditions tested. The main advantage of the method 
described, which warrants its further utilization, is the 
ability to carry out all determinations quantitatively and 
using a single cell incubation well. 
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Table 1 Test distribution of glucose, lactate and glycerol label along the M1 procedure of separation using 
micro ion-exchange columns and elution by centrifugation  
 
fraction % vs. initial 
LABELLED LACTATE 
initial 5 mM 100.0 
first pass of medium W1 0.29±0.08 
water washing W2 0.51±0.03 
HCl elution W3 99.8±0.7 
water washing W4 0.15±0.09 
total recovery 100.8±0.6 
LABELLED GLUCOSE 
initial 7 mM 100.0 
first pass of medium after enzyme incubation W5 0.45±0.03 
water washing W6 0.53±0.09 
HCl elution W7 100.4±3.2 
water washing W8 0.26±0.14 
total recovery 101.6±3.4 
LABELLED GLYCEROL  
initial 1.3 mM 100.0 
first pass of medium after enzyme incubation W9 1.4±0.8 
water washing W10 2.7±0.3 
HCl elution W11 99.5±1.2 
water washing W12 1.7±0.4 
total recovery 105.6±2.0 
 
The data correspond to the mean ± sem values of four separate analyses for each label, as explained in the text.  
 
Table 2  Effect of the presence of antibiotics in the yield of labelled "glycerol" in the acid-eluted fractions of the 
fraction of glycerol kinase-treated medium after its retention in the ion-interchange columns 
 
units 
glucose label: "glycerol" fraction glucose label: 
"other nonionic 
components 
fraction" * 
without added 
antibiotics 
with added 
antibiotics 
glycerol label in Bq/well 724±190 524±93 428±104 
Bq/µmol of glycerol 591±123 387±64 363±84 
Bq/µmol-C of glycerol 197±41 129±21 121±28 
 
Data are the mean ± sem of 4 different analyses using glucose as initial source of label. 
There were no statistically significant differences between groups for any of the parameters shown (unpaired Student's 
t test) 
* These data were obtained from the analysis of glucose oxidation  
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Table 3  Results obtained in the application of the described analytical process to epididymal adipocytes from 
adult male Wistar rats. Cells and medium parameters before and after 24 h of incubation 
 
 mM 
% of change 
cells or µmol/well ( metabolites) 
initial after 24 h initial after 24 h 
adipocytes (cells x103)   -2 702±47 688±33 
glucose 6.78±0.29 3.73±0.87 -45 12.23±0.41 6.57±1.54 
lactate 0.14±0.04 2.81±0.38 +2x103 0.26±0.08 4.93±0.65 
glycerol 0.014±0.006 0.70±0.07 +5x103 0.023±0.011 1.22±0.12 
 
Data are the mean ± sem of 4 different complete runs (as described in the text) using glucose as initial source of label. 
 
 
Table 4 Results obtained in the application of the described analytical process to epididymal adipocytes from 
adult male Wistar rats. Fraction size and label content 
 
 major compound weight mg volume µL Bq (whole well) 
medium initial   1806±24 4730 
medium aliquot used   275±25 4186±294 
medium pass column [W1+W2] glucose + glycerol  503±7 2893±280 
retained and eluted [W3+W4] lactate + pyruvate  1125±153 1293±228 
glucose-oxidase incubation [W1+W2 
aliquot] 
  100±2  
incubation pass column [W5+W6] glycerol + other  1911±18 429±104 
retained and eluted [W7+W8] glucose  1985±16 2465±326 
glycerol-kinase incubation [W1+W2 
aliquot]   100±3  
incubation pass column [W9+W10] glucose + other  455±44 2491±342 
retained and eluted [W11+W12] glycerol  842±41 269±58 
cells total (density: 0.0975 g/mL)  179±22 197±24 297±116 
solids and aqueous phases 
glycogen + protein 
+ metabolites  497±83  72±9 
lipid extract triacyl-glycerols 106±12  214±97 
potassium soaps fatty acids 159±23  106±56 
liquid phase glycerol + other 205±49  109±43 
losses in cells' fractions  22±25  16±16 
glucose oxidation, losses of label, and 
experimental, measuring and accounting 
errors 
 
  148±210 
 
Data are the mean ± sem of 4 different complete runs (as described in the text) using glucose as initial source of label. 
For calculations, we used glyceroyl-trioleate [MW 887] for triacylglycerols molar equivalences. 
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Table 5 Results obtained in the application of the described analytical process to epididymal adipocytes from 
adult male Wistar rats. Specific activities 
 
 µmol/well Bq/well Bq/µmol Bq/µmolC 
initial medium glucose 12.2±0.4 4730 388±13 65±3* 
medium "glucose" fraction 6.57±1.50 2465±326 444±98 74±16* 
medium "lactate" fraction 4.93±0.65 1290±228 196±26 65±9* 
medium "glycerol" fraction 1.22±0.12 269±58 202±36 67±12* 
cell fatty acids' (soaps) fraction 357±41 106±56 0.26±0.11 0.014±0.006 
cell glycerides-glycerol fraction 119±14 109±43 0.84±0.26 0.28±0.09 
 
Data are the mean ± sem of 4 different complete runs (as described in the text) using glucose as initial source of label. 
* These values were not statistically different. 
 
 
 
 
 
 
 
 
Figure 1 Centrifuge-separation tube with plastic insert 
used in the preparation and use of ion-interchange 
columns. 
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Figure 2 Flow diagram of the process of analysis of the fate of 14C-glucose label in the medium and cells of 
rat epididymal WAT incubated during 24 hours. 
The process is marked in black, red fractions refer to the counting of the fraction radioactivity, and 
blue is reserved for non-radioactive measurements (metabolites, cell parameters). The specific 
procedures explained under "Experimental" are marked in green, and the fractions eluted in purple. 
The four rectangles marked with dashed lines show the specific procedures for lactate, glucose and 
glycerol label separation, and for the processing of cell's fractions. 
glc = glucose; lact = lactate. 
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Figure 3 Percent distribution of labeled glucose (total label and metabolized glucose) after 24 h of incubation 
by epididymal adipocytes 
 The results are the mean ± sem of four different rats 
 TAG = triacylglycerols; FA = fatty acids; prot = protein; lact+pyr = lactate + pyruvate. 
 
